EMA/PE/0000246904 - paediatric investigation plan

cobolimab

Key facts

• Active substance:
  cobolimab
• Therapeutic area:
  Neoplasms benign, malignant and unspecified (incl cysts and polyps)
• Decision number:
  EMA/PE/0000246904
• PIP number:
  EMA/PE/0000246904
• Pharmaceutical form(s):
  Solution for infusion
• Condition(s) / indication(s):
  Treatment of all conditions included in the category of malignant neoplasms including lymphoma
• Route(s) of administration:
  Intravenous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  12/09/2025
• Compliance check done:
  Ne

Decision

EMA/PE/0000246904 : EMA decision of 12 September 2025 on the acceptance of a modification of an agreed paediatric investigation plan for cobolimab

Adopted Reference Number: EMADOC-1700519818-2347002